Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

1.On 14 August 2012, the European Commission received notification of a proposed

concentration pursuant to Article 4 of the EC Merger Regulation by which Bridgepoint

Advisers Group Limited (“Bridgepoint”) and Orlando Italy Management S.A.

(“Orlando”) will indirectly acquire joint control over Limoni S.p.A. (“Limoni”)

within the meaning of Article 3(1)(b) of the EC Merger Regulation.

The primary business activities of the undertakings concerned are:

• Bridgepoint provides private equity to established companies in a broad range

of sectors (including business services, consumer, financial services, healthcare,

industrials and media) to fund buy-outs, buy-ins, growth and public-to-private

transactions.

• Orlando is an independent private equity firm advising and supporting

institutional investors in identifying and acquiring potential portfolio

companies. Orlando also acts as the General Partner of Orlando Italy Special

Situations SICAR S.C.A. (Luxembourg), a company active in investments in

the risk capital of companies.

• Limoni is mainly active in the retail distribution of perfumes and cosmetic

products, principally in Italy.